This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.

Education Hub

 

Acute Myeloid Leukaemia Awareness Survey

Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old. For older patients who receive chemotherapy, the median survival is less than a year.

A perception and awareness survey of 2,520 people from France, Germany, Italy, Spain and UK. conducted in 2014 revealed urgent need to improve education about AML.

Therapy Area

Infographics

 

  •   

    giotrif® (afatinib*) now approved in over 40 countries worldwide

  •  

    volasertib* and polo-like kinase inhibition

  •  

    lume-lung 1 infographic

  •  

    lux-lung 3 & 6 clinical trial results layered infographic

  •  

    afatinib* - irreversible erbb family blocker

  •  

    lung cancer statistics

  •  

    lux-lung 5 infographic

  •   

    lung cancer in asia statistics infographic

  •    

    lux-lung 7 clinical trial infographic

  •  

    lux-lung 8 clinical trial infographic

  •  

    lux-lung clinical trial programme infographic


  •  

    angiokinase inhibition and nintedanib*

  •  

    lung cancer animated infographic

  •  

    ago-ovar, lume-ovar ovarian cancer clinical trials

  •  

    lux-head & neck 1 trial infographic

  •  

    lux-head & neck 2 trial infographic

  •  

    breast cancer symptoms animated infographic

  •  

    ovarian cancer animated infographic

  •  

    breast cancer symptoms animated infographic

  •  

    lume lung 2 clinical trial infographic

  •  

    lume lung 1 clinical trial infographic

  •    

    lux lung 1 clinical trial infographic

  •  

    lux lung 2 clinical trial infographic

  •   

    the changing face of cancer infographic

  •  

    ovarian cancer statistics infographic

  •  

    breast cancer statistics infographic

  •  

    volasertib* and polo-like kinase inhibition

  •   

    head and neck cancer incidence &statistics infographic

  •  

    polo-aml-2

  •   

    acute myeloid leukaemia

  •  

    Acute Myeloid Leukaemia Awareness Survey

    Videos

     

    •  

      acute myeloid leukaemia: a rare disease

    •  

      joining together for rare diseases

    •  

      lung cancer - hear from a patient & and lung cancer: we're listening - dr. matthew peters

    •   

      lume-lung 1 trial - dr. anders mellemgaard

    •   

      bi oncology news: the asian patient perspective

    •    

      nintedanib* mode of action

    •    

      egfr mutations in lung cancer video

    •  

      Highlights from ASCO Press Event

    •    

      lung cancer, not just one disease

    •   

      lux-lung 3 & 6 trials video

    •   

      lung cancer, not just one disease - dr. sanjay popat

    •  

      lung cancer, not just one disease

    •  

      importance of egfr mutation testing

    •  

      asco 2013 afatinib* and nintedanib* data story

    •  

      lux-lung 3 trial design

    •  

      lux-lung 3 results - prof thomas lynch

    •   

      lux lung 6 and other afatinib trials

    •  

      lux-lung 7 & 8 trials

    •  

      lung cancer biomarkers

    •  

      afatinib lung cancer treatment - nsclc with egfr mutation

    •   

      ovarian cancer research and new treatment options

    •   

      ovarian cancer symptoms and characteristics

    •   

      ovarian cancer treatment - targeted therapies

    •   

      ovarian cancer prognosis & late diagnosis

    •   

      head and neck cancer incidence and prognosis

    •    

      head and neck cancer treatments & targeted therapies

    •   

      afatinib head and neck cancer trials

    •  

      targeted lung cancer treatment

    •   

      improving outcomes in lung cancer

    •   

      personalising cancer care and the future of cancer treatments

    •  

      personalised cancer treatment - cancer as chronic disease

    •   

      non small cell lung cancer overview

    •    

      egfr mode of action

    •   

      volasertib* plk 1 inhibitor - oncology compound

    •     

      lume-lung 1 trial - dr. martin reck

    •     

      lung cancer - hear from a patient & an oncology nurse

      Backgrounder

       

      •  

        giotrif® (afatinib®) backgrounder

      •  

        lung cancer backgrounder

      •   

        boehringer ingelheim oncology research and development

      •  

        volasertib* backgrounder

      •  

        nintedanib* backgrounder

      •  

        erbb family backgrounder

      •  

        acute myeloid leukaemia (aml) backgrounder

      •      

        targeted cancer therapies backgrounder

      •    

        cancer statistics and incidence rates

      •      

        breast cancer overview - what is breast cancer?

      •     

        what is ovarian cancer? backgrounder

      •      

        head and neck cancer overview and backgrounder

        Fact sheet

         

        •  

          glossary of terms

        •  

          lux-lung 3 clinical trial fact sheet

        •  

          lux lung 2 clinical trial fact sheet

        •  

          a-z cancer glossary

        •  

          lux lung 1 clinical trial fact sheet